Healthy Aging Health Center
How Old Are You Inside? Blood Test May Tell
June 18, 2009 -- You know how many birthday candles are on your cake, but a new blood test may be able to tell whether you're aging faster, or slower, than you think.
That blood test is described in a new study, published in Aging Cell. It measures a protein called p16 that rises with age, and rises particularly fast if you smoke and don't exercise.
Researcher Norman Sharpless, MD, an associate professor of medicine and genetics at the University of North Carolina School of Medicine in Chapel Hill, N.C., says other scientists identified the p16 gene years ago as a gene that helps prevent cancer. Later research showed that the p16 gene becomes more active as mammals age.
Sharpless and colleagues have created a blood test that measures p16 levels in certain immune system cells called T-cells.
Sharpless says it's the first p16 test for cells that are easy to check. Other cells that contain p16 are in organs that are harder to get to, like the pancreas, he says. "You can't really sample those things," Sharpless tells WebMD. "The advance here is that this is a cell that's easily attainable."
In their new study, 170 healthy North Carolina adults took the p16 blood test and answered questions about their lifestyle. Sharpless and colleagues looked for patterns to gauge participants' "molecular age," based on their p16 blood levels.
Molecular Age Results
The results showed that p16 levels were most strongly linked to chronological age -- the older a person was, the higher their p16 level was -- long before that person would be considered old.
"Even at very young ages, when p16 is not very highly expressed, you can still see a difference with a decade. So you can tell a difference between 20 and 30 year olds, and 30 and 40 year olds," Sharpless says. "Aging occurs well before you're aged."
Smoking was strongly linked to higher levels of p16.
"If you smoke, your p16 is higher at any age, and if you smoke a lot, your p16 is a lot higher," Sharpless says. "I think it's very likely, based on other data, that carcinogens make p16 go up."
Exercise was linked to lower levels of p16. It's not yet clear if exercise lowers p16 levels, or if people who exercise have low p16 levels for some other reason. Perhaps those people have diet habits that keep their p16 level low, Sharpless says.
"I really wouldn't want to make the mistake that has been made recurrently in epidemiologic association studies that try and place some causal relationship between the two, other than just note that there's a strong relationship that's reproducible," he says.
BMI ( body mass index) wasn't related to p16 after the researchers took age into account. That finding surprised Sharpless.
"I would have thought that people who were thinner would have lower p16 for their age. That wasn't true," Sharpless says. "One could infer from that that body mass is not a great predictor of fitness ... it just turned out to be a bad marker of molecular age for us."
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

